2024-05-15T10:33:00-05:00 2023-06-30 872525370 CITRIN COOPERMAN ADVISORS LLC 11400 WEST OLYMPIC BLVD 350 LOS ANGELES CA 90064 990 2022-07-01 223307141 THE PITUITARY SOCIETY INC PITU 3109889486 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 DR SHLOMO MELMED SECRETARY-TREASURER 3109889486 2024-05-14 1 DR SHLOMO MELMED 999009999 0 SHEILA MOGHIMI-KAMRAN P00170368 3104778355 2024-05-14 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DR SHLOMO MELMED 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 798095 0 X X 1994 DE TO PROVIDE SCIENTISTS, CLINICIANS AND TRAINEES WITH THE MOST UP-TO-DATE, RELIABLE RESEARCH AND EDUCATION ON THE BIOLOGY OF THE PITUITARY GLAND AND THE CAUSES, DIAGNOSIS AND TREATMENT OF PITUITARY GLAND RELATED DISEASES, IN ORDER TO IMPROVE PATIENT CARE AND TO PROVIDE A UNIQUELY INTERNATIONAL FORUM FOR PROFESSIONAL GROWTH AND SCIENTIFIC EXCHANGE. 14 14 0 0 0 0 22450 433264 262450 327460 137 27475 2092 9896 287129 798095 2500 0 0 0 0 0 0 0 0 204327 549749 206827 549749 80302 248346 1840975 2298432 31656 240767 1809319 2057665 X OUR MISSION IS TO PROVIDE SCIENTISTS, CLINICIANS AND TRAINEES WITH THE MOST UP-TO-DATE, RELIABLE RESEARCH AND EDUCATION ON THE BIOLOGY OF THE PITUITARY GLAND AND THE CAUSES, DIAGNOSIS AND TREATMENT OF PITUITARY GLAND RELATED DISEASES, IN ORDER TO IMPROVE PATIENT CARE AND TO PROVIDE A UNIQUELY INTERNATIONAL FORUM FOR PROFESSIONAL GROWTH AND SCIENTIFIC EXCHANGE. 0 0 265880 327460 IN JUNE, 2023, WE HELD OUR 18TH INTERNATIONAL PITUITARY CONGRESS IN CHICAGO, IL. TWO HUNDRED AND NINETY-THREE ATTENDEES FROM AROUND THE WORLD ATTENDED THE TWO-AND-A-HALF-DAY CONGRESS. THE BIENNIAL INTERNATIONAL PITUITARY CONGRESS IS AN EDUCATIONAL OPPORTUNITY FOR PITUITARY SPECIALISTS, NEUROENDOCRINOLOGISTS, AND NEUROSURGEONS TO REVIEW THE LATEST RESEARCH AND CLINICAL HIGHLIGHTS REGARDING PATIENTS WITH PITUITARY DISORDERS. SPECIFICALLY, THERE IS A CRITICAL NEED TO BRING TOGETHER AN INTERNATIONAL COMMUNITY OF LABORATORY RESEARCHERS, TRANSLATIONAL AND CLINICIAN SCIENTISTS, AND CLINICIANS TO CONSIDER MAJOR ADVANCES IN PITUITARY DISORDERS AND TIE THEM TO CLINICAL CARE. THIS SCIENTIFIC PROGRAM HIGHLIGHTS KEY ADVANCES IN UNDERSTANDING BASIC PITUITARY AND NEUROENDOCRINE REGULATION AND REVIEWS THESE FINDINGS IN CONJUNCTION WITH STATE-OF-THE-ART MANAGEMENT OF PATIENTS WITH PITUITARY TUMORS, PITUITARY DEFICIENCY STATES AND NEUROENDOCRINE DISORDERS. 10915 OVER THE LAST DECADE, MOST ENDOCRINOLOGY FELLOWSHIP PROGRAMS REDUCED THE TRAINING REQUIREMENTS FROM 3 YEARS TO 2 YEARS TO BE ELIGIBLE FOR BOARD CERTIFICATION. IN PARALLEL, DIABETES AND OBESITY INCIDENCE AND PREVALENCE INCREASED SIGNIFICANTLY, LIMITING CLINICAL EXPERIENCES ON OTHER RARER, NEVERTHELESS SEVERE, AND POTENTIALLY LETHAL DISEASES, SUCH AS PITUITARY DISORDERS. THEREFORE, THE PRECEPTORSHIP COURSE FOR FELLOWS-IN-TRAINING, TAUGHT BY LEADING INTERNATIONAL EXPERTS, AIMS TO ADDRESS SOME OF THESE ISSUES BY REVIEWING FOR TRAINEES' ADVANCEMENTS IN DIAGNOSIS AND TREATMENT OF HYPOPITUITARISM, GROWTH HORMONE DEFICIENCY, CUSHING'S SYNDROME, AND ACROMEGALY. 1564 THE 2022 UPDATES IN DIAGNOSIS AND TREATMENT OF PATIENTS WITH ACROMEGALY: PERSONALIZED APPROACHES AND PARADIGM CHANGES POST COVID-19 WEBINAR'S MISSION WAS TO UPDATE GLOBAL ACROMEGALY APPROACHES, THEREBY ALLOWING CLINICIANS WORLDWIDE TO IMPROVE THEIR PATIENTS' QUALITY OF LIFE, MORBIDITY, AND MORTALITY. IN ORDER TO IMPROVE OUTCOMES AND QUALITY OF LIFE FOR THEIR PATIENTS WITH ACROMEGALY, HEALTHCARE PROFESSIONALS MUST BE MADE AWARE OF NEW MEDICAL THERAPY OPTIONS AND TREATMENT STRATEGIES IN THIS DISEASE SETTING. 66401 THE PANOMEN CLINICAL CLASSIFICATION WORKSHOPS SEEK TO ESTABLISH A COMPREHENSIVE CLASSIFICATION SYSTEM THAT GUIDES PROGNOSIS AND THERAPY OF PITUITARY ADENOMAS. THE 2022 WHO HISTOPATHOLOGY-BASED CLASSIFICATION SYSTEM CAN ONLY BE APPLIED TO CERTAIN LESIONS THAT ARE RESECTED, WHICH REPRESENT FEW CLINICALLY SIGNIFICANT PITUITARY ADENOMAS. THROUGH THE WORKSHOPS A NEW APPROACH IS PROPOSED TO GUIDE PROGNOSIS AND THERAPY OF PITUITARY ADENOMAS BY INTEGRATING CLINICAL, GENETIC, BIOCHEMICAL, RADIOLOGICAL, PATHOLOGICAL, AND MOLECULAR INFORMATION FOR ALL ADENOMAS ARISING FROM ANTERIOR PITUITARY CELL LINEAGES.CHANGES IN THE PATHOLOGICAL CLASSIFICATION OF PITUITARY ADENOMAS TO NEUROENDOCRINE TUMOURS HAS HIGHLIGHTED THE NEED FOR A COMPREHENSIVE SCHEMA THAT GUIDES PROGNOSIS AND OUTCOMES FOR ALL PITUITARY ADENOMAS, INCLUDING THOSE THAT ARE NOT SURGICALLY EXCISED. WE DEVELOPED A COMPREHENSIVE CLASSIFICATION SYSTEM FOR BOTH UNRESECTED AND RESECTED ADENOMAS, INCORPORATING A WIDE RANGE OF RISK FACTORS KNOWN TO AFFECT MORBIDITY AND MORTALITY. 66401 344760 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 14 14 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 CA X DR SHLOMO MELMED 3109889486 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 X KALMON POST MD PRESIDENT 6.00 X X 0 0 0 SHLOMO MELMED MB CHB MACP SECRETARY-TREASURER 6.00 X X 0 0 0 JOHN WASSMDMA CHAIR,NOMINATIONS 0.30 X X 0 0 0 ANDREA GIUSTINA MD CO-DIRECTOR, PROGRAMS 0.30 X X 0 0 0 MARIA FLESERIU MD FACE CO-DIRECTOR, PROGRAMS 0.30 X X 0 0 0 FELIPE F CASANUEVA MD PHD INTERNATIONAL RELATIONS 0.30 X X 0 0 0 LAURENCE KATZNELSON MD PRESIDENT-ELECT 0.30 X X 0 0 0 PHILIPPE CHANSON MD DIRECTOR 0.30 X 0 0 0 RICHARD ROSS MBBS MD FRCP DIRECTOR 0.30 X 0 0 0 NIENKE BIERMASZ MD PHD DIRECTOR 0.30 X 0 0 0 ELIZA GEERMD DIRECTOR 0.30 X 0 0 0 LISA NACHTIGALL MD DIRECTOR 0.30 X 0 0 0 ROSARIO PIVONELLO MD PHD DIRECTOR 0.30 X 0 0 0 YUTAKA TAKAHASHI MD PHD DIRECTOR 0.30 X 0 0 0 0 0 0 0 0 0 0 CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BLVD LOS ANGELES CA 90048 ADVISORY SERVICES 148456 1 22725 410539 433264 PROGRAM REGISTRATION F 611430 297460 297460 PROGRAM EXHIBITOR PAYM 900099 30000 30000 327460 27475 27475 9896 9896 9896 798095 327460 0 37371 16900 16900 723 350 373 30964 9352 21612 3476 3476 22605 22605 287753 284948 2805 8135 8135 SHARED EXPENSES - CEDAR 148456 10000 138456 AWARDS 17505 17505 MERCHANT FEES 13232 13232 549749 344760 204989 0 191859 432890 1632683 1849109 6433 6433 10000 10000 1840975 2298432 31656 240767 31656 240767 X 1809319 2057665 1809319 2057665 1840975 2298432 248346 0 X 0 0 0 X 134123 92756 1464 22450 433264 684057 847904 348673 723830 262450 327460 2510317 982027 441429 725294 284900 760724 3194374 0 43076 43076 43076 43076 3151298 89 6008 338 137 27475 34047 89 6008 338 137 27475 34047 2092 9896 11988 982116 447437 725632 287129 798095 3240409 0.97250 0.99660 0.01050 0.00260 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION PROVIDES EACH MEMBER OF ITS GOVERNING BODY WITH THE FORM 990, BEFORE IT IS FILED, FOR THEIR REVIEW AND ULTIMATE APPROVAL FOR FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION REQUIRES AN ANNUAL RE-EXAMINATION OF CONFLICT OF INTEREST, WHEREBY THE BOARD OF DIRECTORS AND ALL OFFICERS NEED TO SIGN A FORM VERIFIYING THAT THERE ARE NO CONFLICTS OR IF THERE ARE, DISCLOSING THEM. THE ORGANIZATION THEN MONITORS THE DECISION MAKING PROCESS TO ENSURE IT IS NOT TAINTED BY POTENTIAL CONFLICT. FORM 990, PART VI, SECTION C, LINE 19 ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE HELD BY THE DIRECTOR AND ARE AVAILABLE FOR THE PUBLIC TO REVIEW AT ANY TIME.